Azacitidine Celgene Evropska unija - slovenščina - EMA (European Medicines Agency)

azacitidine celgene

celgene europe bv - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastična sredstva - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.

Bivalirudin Accord 250 mg prašek za koncentrat za raztopino za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bivalirudin accord 250 mg prašek za koncentrat za raztopino za injiciranje/infundiranje

accord healthcare - bivalirudin - prašek za koncentrat za raztopino za injiciranje/infundiranje - bivalirudin 250 mg / 1 viala - bivalirudin

Bivalirudin Accord 250 mg prašek za koncentrat za raztopino za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bivalirudin accord 250 mg prašek za koncentrat za raztopino za injiciranje/infundiranje

accord healthcare - bivalirudin - prašek za koncentrat za raztopino za injiciranje/infundiranje - bivalirudin 250 mg / 1 viala - bivalirudin